Literature DB >> 18321813

Towards an optimal treatment strategy for patients with oesophageal cancer.

Javier Gallego Plazas, Vanesa Pons Sanz.   

Abstract

Entities:  

Mesh：

Year:  2008        PMID： 18321813     DOI： 10.1007/s12094-008-0168-y

Source DB:  PubMed          Journal:  Clin Transl Oncol        ISSN： 1699-048X            Impact factor:   3.405


× No keyword cloud information.
  22 in total

Review 1.  Epidemiology of esophageal adenocarcinoma.

Authors:  Manuel Pera; Carlos Manterola; Oscar Vidal; Luis Grande
Journal:  J Surg Oncol       Date:  2005-12-01       Impact factor: 3.454

Review 2.  Chemoradiation in the management of esophageal cancer.

Authors:  Lawrence Kleinberg; Arlene A Forastiere
Journal:  J Clin Oncol       Date:  2007-09-10       Impact factor: 44.544

3.  Gene expression profiling of localized esophageal carcinomas: association with pathologic response to preoperative chemoradiation.

Authors:  Rajyalakshmi Luthra; Tsung-Teh Wu; Madan G Luthra; Julie Izzo; Enrique Lopez-Alvarez; Li Zhang; Jaime Bailey; Jeffrey H Lee; Robert Bresalier; Asif Rashid; Stephen G Swisher; Jaffer A Ajani
Journal:  J Clin Oncol       Date:  2005-12-12       Impact factor: 44.544

4.  Chemoradiation with and without surgery in patients with locally advanced squamous cell carcinoma of the esophagus.

Authors:  Michael Stahl; Martin Stuschke; Nils Lehmann; Hans-Joachim Meyer; Martin K Walz; Siegfried Seeber; Bodo Klump; Wilfried Budach; Reinhard Teichmann; Marcus Schmitt; Gerd Schmitt; Claus Franke; Hansjochen Wilke
Journal:  J Clin Oncol       Date:  2005-04-01       Impact factor: 44.544

5.  Chemoradiation followed by surgery compared with chemoradiation alone in squamous cancer of the esophagus: FFCD 9102.

Authors:  Laurent Bedenne; Pierre Michel; Olivier Bouché; Chantal Milan; Christophe Mariette; Thierry Conroy; Denis Pezet; Bernard Roullet; Jean-François Seitz; Jean-Philippe Herr; Bernard Paillot; Patrick Arveux; Franck Bonnetain; Christine Binquet
Journal:  J Clin Oncol       Date:  2007-04-01       Impact factor: 44.544

6.  Survival benefits from neoadjuvant chemoradiotherapy or chemotherapy in oesophageal carcinoma: a meta-analysis.

Authors:  Val Gebski; Bryan Burmeister; B Mark Smithers; Kerwyn Foo; John Zalcberg; John Simes
Journal:  Lancet Oncol       Date:  2007-03       Impact factor: 41.316

Review 7.  Mechanisms of disease: Radiosensitization by epidermal growth factor receptor inhibitors.

Authors:  Carolyn I Sartor
Journal:  Nat Clin Pract Oncol       Date:  2004-12

8.  Chemotherapy for carcinoma of the esophagus: a comparison of evidence from meta-analyses of randomized trials and of historical control studies.

Authors:  M S Bhansali; J S Vaidya; R G Bhatt; P K Patil; R A Badwe; P B Desai
Journal:  Ann Oncol       Date:  1996-04       Impact factor: 32.976

Review 9.  Preoperative radiotherapy for esophageal carcinoma.

Authors:  S J Arnott; W Duncan; M Gignoux; H S Hansen; B Launois; K Nygaard; M K B Parmar; A Rousell; G Spilopoulos; G Stewart; J F Tierney; M Wang; Z Rhugang
Journal:  Cochrane Database Syst Rev       Date:  2005-10-19

Review 10.  Staging of oesophageal cancer.

Authors:  Stefan Diederich
Journal:  Cancer Imaging       Date:  2007-10-01       Impact factor: 3.909
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.